B-cell lymphoma 2 (BCL-2) and other BCL-2-like family members of proteins such as BCL-XL and MCL-1 are highly expressed in leukemia such as acute myeloid leukemia (AML) and account for treatment resistance to chemotherapeutics [1,2]. Here, BCL2L1 is linked to acute myeloid leukemia.